News

PFF Summit 2025 Set to Feature Renowned Keynote Speakers

PFF Summit 2025 Set to Feature Renowned Keynote Speakers

PFF Summit 2025 Set to Feature Renowned Keynote Speakers

The Pulmonary Fibrosis Foundation (PFF) has announced an exciting lineup of keynote speakers for the upcoming PFF Summit 2025, scheduled for November 13–15. This premier event will focus on the latest advancements in pulmonary fibrosis (PF) and interstitial lung disease (ILD). Notably, this year's summit is held in a city celebrated for its vibrant culture and commitment to health innovation.

Keynote Speakers Highlight the Summit

The PFF Summit has attracted leading experts whose contributions are shaping the future of care for those affected by pulmonary diseases. Notable speakers include:

Karen Mancera-Cuevas, DrPH

Dr. Karen Mancera-Cuevas, Senior Director of Health Equity at the National Health Council, will delve into the crucial topic of equitable participation in clinical trials. Her insights aim to empower and advocate for diverse representation in clinical research, ensuring that all patient voices are heard.

James Fraser, PhD

Dr. James Fraser, an authority in bioengineering and therapeutic sciences, will explore how artificial intelligence (AI) is revolutionizing drug discovery processes. His presentation will highlight innovative approaches to developing new treatments for PF and ILD, emphasizing the significant potential of technology in medicine.

Star Power at the Summit

One of the standout features of this year's summit is the participation of Broadway star and PFF advocate, Julie Halston. As the host of the Dine and Delight Networking Night, Halston brings her unique flair and genuine passion for raising awareness around pulmonary fibrosis.

Having lost her husband to the disease, Halston's advocacy is deeply personal. Her involvement adds a poignant touch to the summit, making it not only an educational experience but also a heartfelt gathering that celebrates life and resilience.

Advancements in Pulmonary Medicine

According to PFF President and CEO Scott Staszak, recent years have witnessed remarkable strides in the understanding and treatment of PF and ILD. "The summit serves as a vital platform for patients and healthcare providers to learn from each other's experiences and the latest medical advancements," he stated.

With over 250,000 Americans battling pulmonary fibrosis and interstitial lung disease, the summit is committed to offering valuable sessions tailored to diverse audiences. This includes patients, caregivers, lung transplant recipients, and healthcare professionals, ensuring that everyone walks away with knowledge and hope.

Celebrating 25 Years of Commitment

This year marks a significant milestone, celebrating the 25th anniversary of the Pulmonary Fibrosis Foundation. The foundation has played a pivotal role in advocating for research and support for individuals affected by PF. Its distinguished efforts have been recognized nationally, positioning it as a leader in the field.

As the event approaches, individuals are encouraged to register early to secure their spot at this transformative experience. More information is available, outlining how to participate in the summit and contribute to the ongoing discussions about pulmonary health.

About the Pulmonary Fibrosis Foundation

The mission of the Pulmonary Fibrosis Foundation is to accelerate the development of innovative treatments for pulmonary fibrosis while enhancing the care of patients. Their commitment extends to providing unparalleled support through educational resources for patients, caregivers, and health care professionals alike.

Contact Information: For additional questions regarding the summit or to arrange interviews with speakers, please reach out to Dorothy Coyle, Pulmonary Fibrosis Foundation, at 773-332-6201.

Frequently Asked Questions

What is the PFF Summit 2025?

The PFF Summit 2025 is a leading conference focused on pulmonary fibrosis, bringing together experts and patients to share insights and advancements in treatment.

Who are the keynote speakers at the summit?

Keynotes include Dr. Karen Mancera-Cuevas who will discuss clinical trials, and Dr. James Fraser who will talk about AI in drug discovery.

When is the summit taking place?

The summit is scheduled from November 13-15.

How can I register for the summit?

Registration details can be found on the Pulmonary Fibrosis Foundation website.

What milestone is the PFF celebrating this year?

This year marks the 25th anniversary of the Pulmonary Fibrosis Foundation, highlighting its dedication and impact in the field.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Rutter Mills Expands Turkey Giveaway to Two Cities

Updated Category News Views 78

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

Continue Reading
James Hardie Joins S&P MidCap 400; Roku Acquired

Updated Category News Views 97

A Shift in the MidCap 400: What's Up? Well, wouldn’t you know it, James Hardie Industries is making waves as it steps into the S&P MidCap 400. This move happens because Fox Corp. has nabbed Roku in a deal worthy of some popcorn. Come November 11, when the trading floor wakes up, James Hardie will be in and Roku will be out. Pretty neat switcheroo if you ask me. Inside...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 185

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 76

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 194

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 115

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Pinterest Faces Legal Probe: Investor Concerns Rise

Updated Category News Views 95

Legal Storms Gather on Pinterest's Horizon I remember a time when Pinterest was the darling of Wall Street, but here we are, staring at an investigation that's got more layers than an onion. On November 6, 2026, news broke that Kahn Swick & Foti, LLC (KSF) is sniffing around Pinterest's officers and directors. This is no small fry since KSF is steered by none other than...

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 133

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 108

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 157

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading

Top 5 Most Recently Viewed Articles

Alex Bastian Named VP of Commercial Strategy at Memo Therapeutics

Updated Category News Views 287

Alex Bastian Appointed as VP of Commercial Strategy at Memo Therapeutics AG Memo Therapeutics AG (or “MTx”), a late-stage biotech firm committed to transforming unique human immune responses into effective treatments for viral infections and cancer, has announced the appointment of Alex Bastian as its new VP of Commercial Strategy. Expertise in the Biotech Industry...

Continue Reading
AST SpaceMobile Partners with SDA to Advance Space Technology

Updated Category News Views 241

AST SpaceMobile's New Partnership with the Space Development Agency AST SpaceMobile, Inc. (NASDAQ: ASTS), a pioneering company in the development of the world's first space-based cellular broadband network, has made a significant stride by securing an initial contract with the Space Development Agency (SDA). This selection as a prime contractor represents a substantial...

Continue Reading
CIP Chemicals Market Set to Reach $3.69 Billion by 2029

Updated Category News Views 134

Exploring the Growth of the CIP Chemicals Market The CIP Chemicals Market is on an exciting trajectory, with projections indicating remarkable growth in the coming years. Analysts anticipate that the market will expand from USD 2.40 billion in 2024 to an impressive USD 3.69 billion by the year 2029. This growth signals a compound annual growth rate (CAGR) of 9.0%,...

Continue Reading
Rocket Lab Expands Partnership with iQPS for Future Missions

Updated Category News Views 217

Rocket Lab Partners with iQPS for Key Missions Rocket Lab USA, Inc. (Nasdaq: RKLB) has announced a significant contract with Institute for Q-shu Pioneers of Space, Inc. (iQPS), further solidifying its position as a leading provider of satellite launches. This new agreement includes three dedicated Electron missions, which will begin launching as early as 2026 from Rocket...

Continue Reading
Vinpai's Revenue and Growth Strategy: A 2024 Review

Updated Category News Views 111

Vinpai dropped its half-year numbers for 2024, and let me tell ya, it’s a mixed bag of good and bad. Sure, they reported a nice jump in sales—28% year-over-year to €5,111k—but you gotta dig deeper to see the cracks forming underneath that shiny surface. Revenue Growth vs. Margin Squeeze: What's the Real Deal? The revenue growth? That’s the feel-good story...

Continue Reading